Class Action Lawsuit Alleges Dove Sensitive Body Wash Falsely Advertised as ‘Hypoallergenic’

New to ClassAction.org? Read our Newswire Disclaimer

A proposed class action lawsuit claims that Conopco, Inc. falsely touts its Dove sensitive body wash as hypoallergenic when the product contains a known skin-irritating fragrance ingredient.

Want to stay in the loop on class action lawsuits that matter to you? Sign up for ClassAction.org’s free weekly newsletter.

The 30-page complaint contends that although Conopco markets Dove Sensitive Hypoallergenic Body Wash as safe for those with sensitive skin, independent testing has shown that the product contains d-Limonene, one of 26 fragrance allergens recognized by the Food and Drug Administration (FDA).

According to the lawsuit, the “hypoallergenic” label appears prominently on both the front and back of the Dove body wash bottle, suggesting to consumers that the product is formulated without ingredients known to trigger skin irritation or reactions.

However, the lawsuit argues that Conopco fails to clearly disclose to consumers the alleged presence of d-Limonene in its product, which renders the “hypoallergenic” representations false and misleading.

“By deceiving consumers about the nature, quality, and formulation of its Product, [Conopco] was able to capture market share from competing products and command a price premium, increasing its own sales and profits,” the complaint asserts.

The complaint bases its allegations on testing conducted in April 2026 by an independent laboratory, which allegedly detected d-Limonene in the Dove hypoallergenic body wash. The suit claims that d-Limonene is likely included within the product’s generic “fragrance” ingredient listing.

According to the complaint, d-Limonene is a fragrance compound commonly used in beauty and personal care products solely for the “aesthetic purpose” of adding scent. Per the case, the American Academy of Dermatology has recognized fragrance ingredients as skin irritants and a leading cause of contact dermatitis.

The case alleges that growing consumer demand for hypoallergenic products has enabled companies to charge premium prices for products marketed as less likely to cause irritation.

“Given the increased prevalence of allergic contact dermatitis and other skin conditions, consumers increasingly seek clean products looking for and relying on terms such as ‘hypoallergenic’ in making purchasing decisions,” the filing states.

Consumers reasonably understand the term “hypoallergenic” to mean a product is specifically formulated to reduce the likelihood of allergic reactions compared to regular products, including through the avoidance of known irritants, the suit says. The complaint notes that the FDA has similarly acknowledged that products labeled as hypoallergenic are understood to produce fewer adverse reactions.

Because consumers have no practical way to independently verify whether a product contains fragrance allergens, they must rely on the manufacturer’s labeling and marketing to accurately represent the product’s qualities and ingredients, the suit argues.

According to the case, consumers who observed the “hypoallergenic” claim on the Dove sensitive body wash reasonably believed that it would not include ingredients like d-Limonene that are “widely recognized” as a common cause of allergic contact dermatitis.

The Dove class action lawsuit seeks to represent all consumers who purchased Dove Sensitive Hypoallergenic Body Wash in the United States during the maximum statute of limitations period permitted by law.

Check out ClassAction.org’s lawsuit list for the latest open class action lawsuits and investigations.